Tel Aviv HaHagana

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of a leukemia drug development and biopharma acquisition theme, illustrating why Merck’s $6.7bn Terns Pharmaceuticals deal and TERN-701 are drawing attention as the Keytruda patent cliff approaches.

Merck’s $6.7bn Terns Pharmaceuticals buy puts CML drug TERN-701 in play as Keytruda patent cliff nears

Representative image of an Infosys office building, reflecting the firm’s global push to scale Topaz as a full-stack generative AI transformation platform.

Why is Infosys buying Stratus now as insurance platform modernization enters an AI-heavy phase?

Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move

Boliden AB (STO: BOL) warns Garpenberg seismic damage will cut 2026 output and hit Q1 EBITDA

Representative image of Israel Railways train at Tel Aviv station as services resume after repairs, with full nationwide restoration expected by September 1.

Israel Railways fast-tracks repairs after accident—will September mark a turning point for reliability?

Israel Railways to resume Tel Aviv train services on Sunday after a weeklong suspension, with full nationwide operations set for September 1. Read the details here.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

August 24, 2025